NervGen Pharma
0 followers
NGEN
Performance
About NervGen Pharma
NervGen Pharma is a clinical-stage biopharmaceutical company focused on developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic disorders. Its lead candidate NVG-291 is being evaluated in the Phase 1b/2a CONNECT SCI study, with a portfolio addressing neuroregeneration and recovery in neurologic conditions. The company is headquartered in Vancouver, British Columbia, and maintains an active presence in North American markets with a focus on translating nerve repair science into clinical applications.